KIA
CORV

Kopp Investment Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Kopp Investment Advisors’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-17,280
Closed -$61K – 76
2013
Q3 		$61K Hold
17,280
– – 0.02% 87
2013
Q2 		$34K Buy
+17,280
New +$34.7K 0.01% 93

Other funds holding CORV

FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
Alistair Capital Management Dallas, Texas $391M AUM 5.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Kopp Investment Advisors's CORV Position: Q4 2013 in Review

Kopp Investment Advisors sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2013, closing a stake of 17,280 shares — an estimated $61K sold.

Kopp Investment Advisors first reported a position in CORV in Q2 2013 and held it in 2 quarters. The position peaked at $61K in Q3 2013. 27 funds tracked by Wall St. Rank hold CORV as of Q4 2013.

  • Kopp Investment Advisors reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2013 after selling out during the quarter.
  • Kopp Investment Advisors sold 17,280 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2013, an estimated $61K.
  • Kopp Investment Advisors first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2013 and held it in 2 quarters.
  • Kopp Investment Advisors's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $61K in Q3 2013.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2013.

Based on Kopp Investment Advisors's 13F filing for Q4 2013, filed 21 Jan 2014.